Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P I Borgen

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Annals of Surgical Oncology|August 18, 2001
Highest isotope count does not predict sentinel node positivity in all breast cancer patientsR C Martin, J Fey, H Yeung, et al.
Journal of the American College of Surgeons|June 13, 2001
The breast cancer patient with multiple sentinel nodes: when to stop?M D McCarter, H Yeung, J Fey, et al.
Cancer|May 1, 1995
Mutations of the p53 gene in male breast cancerA Anelli, T F Anelli, B Youngson, et al.
Journal of Medical Genetics|January 7, 2005
Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer casesS-W Kim, C S Lee, J V Fey, et al.
Surgery, Gynecology & Obstetrics|March 1, 1992
Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapyM P Osborne, P I Borgen, G Y Wong, et al.
Journal of the American College of Surgeons|July 11, 1998
Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapyS H Kim, A Simkovich-Heerdt, K N Tran, et al.
Cancer Research|September 1, 1997
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomasE Rhei, L Kang, F Bogomolniy, et al.
Cancer|July 1, 1994
Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patientsT F Anelli, A Anelli, K N Tran, et al.
Annals of Surgical Oncology|April 13, 2000
Women's regrets after bilateral prophylactic mastectomyD K Payne, C Biggs, K N Tran, et al.
Annals of Surgery|May 11, 1999
Credentialing for breast lymphatic mapping: how many cases are enough?H S Cody, A D Hill, K N Tran, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Annals of Surgical Oncology|August 18, 2001
Highest isotope count does not predict sentinel node positivity in all breast cancer patientsR C Martin, J Fey, H Yeung, et al.
Journal of the American College of Surgeons|June 13, 2001
The breast cancer patient with multiple sentinel nodes: when to stop?M D McCarter, H Yeung, J Fey, et al.
Cancer|May 1, 1995
Mutations of the p53 gene in male breast cancerA Anelli, T F Anelli, B Youngson, et al.
Journal of Medical Genetics|January 7, 2005
Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer casesS-W Kim, C S Lee, J V Fey, et al.
Surgery, Gynecology & Obstetrics|March 1, 1992
Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapyM P Osborne, P I Borgen, G Y Wong, et al.
Journal of the American College of Surgeons|July 11, 1998
Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapyS H Kim, A Simkovich-Heerdt, K N Tran, et al.
Cancer Research|September 1, 1997
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomasE Rhei, L Kang, F Bogomolniy, et al.
Cancer|July 1, 1994
Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patientsT F Anelli, A Anelli, K N Tran, et al.
Annals of Surgical Oncology|April 13, 2000
Women's regrets after bilateral prophylactic mastectomyD K Payne, C Biggs, K N Tran, et al.
Annals of Surgery|May 11, 1999
Credentialing for breast lymphatic mapping: how many cases are enough?H S Cody, A D Hill, K N Tran, et al.
Pageof 9